ArticleBMC cancer2010

Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.

Ymera Pignochino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.